Natco Pharma announced that the Appeals Court in the US has rejected its marketing partner Alvogens appeal on Ibrutinib Tablets of 140 mg 280 mg 420 mg and 560 mg strength proposed generic equivalents to Imbruvica Tablets
Natco and its co-development amp; marketing partner Alvogen Pine Brook LLC USA are assessing their option on the way forward
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
